Article Listing - Positive first Phase III trial of an alpha-pharmaceutical, Bayer’s Alpharadin

US FDA IMPORT DETENTIONS

13 April 1992

In the first quarter of fiscal 1992, running from October to December 31, 1991, US Food and Drug Administra-tion officials...

GERMAN BPI: MORE PATIENT CHARGES

13 April 1992

The German pharmaceutical industry association, the BPI, has called for the principle under which patients contribute to the cost of...

SUSPENSION OF DPT VACCINE

13 April 1992

Following the decision by the Department of Health in the Republic of China for an immediate temporary suspension of the...

PASTEUR MERIEUX HIB VACCINE

13 April 1992

Pasteur Merieux has launched Hemophilus influenzae type B conjugate vaccine, called Act-HIB, onto the French market.

FORTHCOMING MEETINGS

13 April 1992

Pharmaceutical industry meetings to be held in London by Management Forum shortly include:

- Improving Drug Development: Principles and Practice of...

"ROLLING" NDA FOR ADRIA'S RIFABUTIN

13 April 1992

A New Drug Application for Adria Laboratories' rifabutin, a product under development as a treatment for opportunistic Mycobacterium avium complex...

UPJOHN UPDATES ON R&D PROGRESS

13 April 1992

As the 1990s progress, US pharmaceutical company Upjohn faces a situation where several of its high-earning products will come to...

IMPROVED METERED DOSE INHALER

13 April 1992

Armstrong Pharmaceuticals has signed an exclusive license agreement option for an improved metered dose inhaler from Texax-Glynn Corp. The device...

CONTINENTAL CLOSES BIOLOGICALS DIVISION SALE

13 April 1992

Continental Pharma Cryosan Inc reports that it has received a cash payment of $16.9 million on closing the sale of...

NOVO-NORDISK'S rec INSULIN LAUNCHED IN FRANCE

13 April 1992

Novo-Nordisk has launched four formulations of its recombinant human insulin under the trade name Mixtard HMge Penfill. All the formulations...